HomeAI · summaries
Storia in 3 fonti
Prader-Willi syndrome groups call attention to possible safety risks with Vykat XR
A joint statement issued by three organizations warned healthcare professionals about potential safety risks for patients receiving a newly approved therapy to treat Prader-Willi syndrome. Prader-Willi Syndrome Association USA, the Foundation for Prader-Willi Research and the International Prader-Willi Syndrome Organization released a statement to raise awareness about reports of serious adverse
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
medpagetoday.com
Experts Flag Potential Safety Concerns in New Prader-Willi Drug
7 deaths and over 100 serious adverse events reported to FDA after treatment with Vykat XR
- ·
endpoints.news
Four questions on new safety warnings for Neurocrine’s Vykat XR
The treatment has been linked to seven deaths, largely due to heart or respiratory problems. It has also been associated with over 100 serious adverse events in Prader-Willi…
